Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TB4 Collagen/Chitosan Sponge for Difficult to Heal Wounds
NCT02668055Phase 1Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of thymosin beta-4 in wound, sponsored by Chinese PLA General Hospital. Primary endpoint: Frequency of Adverse Events at 6 months. Started Jan 2012; status: completed.
02
Drugs
thymosin beta-4
03
Conditions
wound
Beyond the preview
Go deeper on NCT02668055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668055.